hengrui glp-1 π ORAL UPDATE π Kailera/Hengrui's HRS-7535 showed 9.8% weight loss in a 44-week Phase 3 trial in China. π¨π³ While effective and free of hepatotoxicity, high rates of nausea (70%) and The Race Is On: Winning
Pay in 4 interest-free payments of $5.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 1 - Aug 6
























